Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0699790 (colon cancer)
 28,837 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

During the last 18 years, considerable research has been conducted on the role of dietary fiber in health and disease. Interest was stimulated by epidemiologic studies that associated a low intake of dietary fiber with the incidence of colon cancer, heart disease, diabetes, and other diseases and disorders. Dietary fiber is not a single substance. There are significant differences in the physiological effects of the various components of dietary fiber. A Recommended Dietary Allowance for dietary fiber has not been established. However, an adequate amount of dietary fiber can be obtained by choosing several servings daily from a variety of fiber-rich foods such as whole-grain breads and cereals, fruits, vegetables, legumes, and nuts.
Conn Med 1989 Sep
PMID:Dietary fiber and health. AMA council on Scientific Affairs. 255 5

Pelvic schwannomas are rare; it is even more rare for a pelvic schwannoma to occur concurrently with a colon cancer. The authors report the case of a 62-year-old woman with a cecal mass that was surgically removed and the histopathologic diagnosis was adenocarcinoma of the colon. Meanwhile, aretroperitonealpelvic nodalmasswas detected as questionable metastasis of the primary tumor. A subsequent computed tomography-guided fine-needle biopsy was carried out to establish the tumor stage. Surprisingly, the fine-needle biopsy revealed a benign schwannoma. This unusual case posed a dilemma in postoperative staging of the colon cancer.
Conn Med 2011 Feb
PMID:Synchronous colonic adenocarcinoma and pelvic schwannoma. 2147 79

Traditionally, cardiac metastases and lymphangitic carcinomatosis have been associated with survival of only two to four months. We report herein a patient with malignant pericardial. effusion, and lymphangitic carcinomatosis due to colon cancer who remains in partial remission 12 months after the diagnosis. We postulate that the newer agents bevacizumab and cetuximab used in two different combination regimens contributed significantly to his longer survival. If confirmed, increased survival in this group of patients treated with novel regimens will have to be considered before any life-changing decisions (such as early referral to hospice) are made. In addition, a multitude of newer agents are in the pipeline and will soon join the battle against gastrointestinal malignancies, which could further increase survival in these patients.
Conn Med 2016 Sep
PMID:Prolonged Survival in Colon Cancer with Malignant Pericardial Effusion and Pulmonary Lymphangitic Carcinomatosis: A Case for Monoclonal Antibodies? 2978 85